These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


753 related items for PubMed ID: 18233989

  • 1. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C, Barreiro P, Martín-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, García-Gascó P, García-Samaniego J, Soriano V.
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [Abstract] [Full Text] [Related]

  • 6. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R, Singla V, Kacharya Sk.
    Trop Gastroenterol; 2008 Dec; 29(3):136-47. PubMed ID: 19115605
    [Abstract] [Full Text] [Related]

  • 10. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, Dustov A, Mizokami M.
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, Rela M, Heaton N, O'Grady JG.
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [Abstract] [Full Text] [Related]

  • 12. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.
    Antonucci G, Vairo F, Iacomi F, Comandini UV, Solmone M, Piselli P, Boumis E, Lauria FN, Capobianchi MR, Ippolito G, Puro V.
    Scand J Infect Dis; 2008 Oct; 40(11-12):928-34. PubMed ID: 18651264
    [Abstract] [Full Text] [Related]

  • 13. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M.
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
    Blanco F, Barreiro P, Ryan P, Vispo E, Martín-Carbonero L, Tuma P, Labarga P, Medrano J, González-Lahoz J, Soriano V.
    J Viral Hepat; 2011 Jan; 18(1):11-6. PubMed ID: 20088890
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A, Grafihco Study Team.
    J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
    Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF.
    J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
    Brehar-Cioflec D, Vajda A, Negrea DA, Străin R, Tudose N, Sporea I, Moldovan R, Chidioşan C, Chirileanu O, Gaiţă-Criveanu D.
    Rom J Virol; 1995 May; 46(3-4):107-13. PubMed ID: 9179963
    [Abstract] [Full Text] [Related]

  • 20. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections.
    Mathews G, Bhagani S.
    J HIV Ther; 2003 Nov; 8(4):77-84. PubMed ID: 14671504
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.